<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02094118</url>
  </required_header>
  <id_info>
    <org_study_id>13-005965</org_study_id>
    <nct_id>NCT02094118</nct_id>
  </id_info>
  <brief_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</brief_title>
  <official_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Systems Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced&#xD;
      Red Blood Cells reduces pulmonary complications when compared to standard-of-care&#xD;
      Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">May 30, 2019</completion_date>
  <primary_completion_date type="Actual">May 30, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.</measure>
    <time_frame>18 hours after the initiation of the first red blood cell transfusion.</time_frame>
    <description>This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of &quot;Off-protocol&quot; Transfusions</measure>
    <time_frame>Day of surgery. Approximately 1 day.</time_frame>
    <description>The number of standard issued red blood cell units that were transfused to study participants in the washed red blood cell arm of the trial. Additionally, emergency red blood cell transfusions in the standard issued arm of the trial that were administered outside of the study protocol were also included to the definition of &quot;off protocol&quot; transfusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Recipient Hemoglobin</measure>
    <time_frame>Pre to 6 hours post transfusion</time_frame>
    <description>Change in Hemoglobin from pre-transfusion to post-transfusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Recipient Cell Free Hemoglobin(CFH)</measure>
    <time_frame>Pre transfusion until study day 5 or hospital discharge, approximately 5 days</time_frame>
    <description>Change in CFH from pre-transfusion to worst (highest/maximum) post-transfusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Haptoglobin</measure>
    <time_frame>Pre transfusion to study day 5 or hospital discharge, approximately 5 days</time_frame>
    <description>Change in Haptoglobin from pre-transfusion to worst (minimum) post-transfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>Up to hospital day 28, or discharge, whichever comes first</time_frame>
    <description>Number of hours subject received mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Oxygen Supplementation</measure>
    <time_frame>Up to day 28, or hospital discharge, whichever comes first</time_frame>
    <description>Number of hours subjects received supplemental oxygen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sequential Organ Failure Assessment (SOFA) Score</measure>
    <time_frame>Through postoperative day 5.</time_frame>
    <description>Worst SOFA score between Day 1 and Day 5. SOFA scores range from 0-24 with 0 meaning no organ dysfunction and 24 means severe dysfunction of all organ systems evaluated. Each of 6 organ systems are scored on a 0-4 scale with the cumulative score being the total SOFA score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Up to day 28</time_frame>
    <description>Number of days subject remained in the hospital following their surgical procedure. If the number of days the subject remained in the hospital exceeded 28, a value of 28 is assigned.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Transfusion Respiratory Complications.</measure>
    <time_frame>Up to day 28</time_frame>
    <description>Development of transfusion-related lung injury (TRALI) or transfusion-associated circulatory overload (TACO).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">171</enrollment>
  <condition>Blood Transfusion Complications</condition>
  <arm_group>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red blood cells that are administered in the normal fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Point-of-Care washed red blood cell transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Red blood cells that are washed at the point-of-care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Point-of-care washed red blood cell transfusion.</intervention_name>
    <arm_group_label>Point-of-Care washed red blood cell transfusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Standard of care red blood cell transfusion.</intervention_name>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age equal to or greater than 18 years of age.&#xD;
&#xD;
          -  Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, Minnesota or&#xD;
             Duke University Medical Center in Durham, North Carolina&#xD;
&#xD;
          -  At risk for needing at least 4 units of blood during/after surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Immunoglobulin A (IgA) deficiency&#xD;
&#xD;
          -  History of severe recurrent transfusion reactions&#xD;
&#xD;
          -  Refusal to receive allogeneic blood products&#xD;
&#xD;
          -  Refusal to provide informed consent&#xD;
&#xD;
          -  Prevalent lung injury prior to randomization&#xD;
&#xD;
          -  Prevalent congestive heart failure prior to randomization&#xD;
&#xD;
          -  Expected hospital stay &lt; 48 hours&#xD;
&#xD;
          -  Not anticipated to survive &gt; 48 hours&#xD;
&#xD;
          -  Previously enrolled in this trial&#xD;
&#xD;
          -  No plan for placement of a pulmonary artery catheter&#xD;
&#xD;
          -  Use of home oxygen therapy&#xD;
&#xD;
          -  Complex RBC antibody profiles&#xD;
&#xD;
          -  Need for the use of irradiated RBCs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daryl Kor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 19, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2014</study_first_posted>
  <results_first_submitted>February 8, 2021</results_first_submitted>
  <results_first_submitted_qc>March 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 6, 2021</results_first_posted>
  <disposition_first_submitted>April 21, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>April 21, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 27, 2020</disposition_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Daryl J. Kor, M.D.</investigator_full_name>
    <investigator_title>Associate Professor of Anesthsiology</investigator_title>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <keyword>RBC</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <keyword>transfusion related acute lung injury (TRALI)</keyword>
  <keyword>transfusion associated circulatory overload (TACO)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Transfusion Reaction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 17, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT02094118/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care Red Blood Cell Transfusion</title>
          <description>Red blood cells that are administered as standard of care.&#xD;
Standard of care red blood cell transfusion.</description>
        </group>
        <group group_id="P2">
          <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
          <description>Red blood cells that are washed at the point-of-care.&#xD;
Point-of-care washed red blood cell transfusion.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="85"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="81"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care Red Blood Cell Transfusion</title>
          <description>Red blood cells that are administered in the normal fashion.&#xD;
Standard of care red blood cell transfusion.</description>
        </group>
        <group group_id="B2">
          <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
          <description>Red blood cells that are washed at the point-of-care.&#xD;
Point-of-care washed red blood cell transfusion.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="85"/>
            <count group_id="B2" value="86"/>
            <count group_id="B3" value="171"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.1" spread="11.4"/>
                    <measurement group_id="B2" value="65.0" spread="12.1"/>
                    <measurement group_id="B3" value="65.6" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Biomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.</title>
        <description>This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.</description>
        <time_frame>18 hours after the initiation of the first red blood cell transfusion.</time_frame>
        <population>Patients undergoing cardiac surgery who were predicted to be at high risk for requiring red blood cell transfusion.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells transfusion that were administered in the standard of care</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells transfusion that were washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.</title>
          <description>This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.</description>
          <population>Patients undergoing cardiac surgery who were predicted to be at high risk for requiring red blood cell transfusion.</population>
          <units>units on a scale (pg/ml)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101" lower_limit="57" upper_limit="197"/>
                    <measurement group_id="O2" value="105" lower_limit="70" upper_limit="191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="6" upper_limit="23"/>
                    <measurement group_id="O2" value="15" lower_limit="7" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>vWF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" lower_limit="84" upper_limit="137"/>
                    <measurement group_id="O2" value="111" lower_limit="74" upper_limit="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RAGE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3262" lower_limit="2326" upper_limit="6899"/>
                    <measurement group_id="O2" value="4516" lower_limit="2354" upper_limit="5907"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SP_D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7238" lower_limit="4962" upper_limit="11900"/>
                    <measurement group_id="O2" value="7061" lower_limit="4470" upper_limit="13318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PAI_1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73418" lower_limit="38900" upper_limit="196491"/>
                    <measurement group_id="O2" value="53829" lower_limit="21044" upper_limit="151009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ICAM_1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="404914" lower_limit="313796" upper_limit="513060"/>
                    <measurement group_id="O2" value="404129" lower_limit="309411" upper_limit="538055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of &quot;Off-protocol&quot; Transfusions</title>
        <description>The number of standard issued red blood cell units that were transfused to study participants in the washed red blood cell arm of the trial. Additionally, emergency red blood cell transfusions in the standard issued arm of the trial that were administered outside of the study protocol were also included to the definition of &quot;off protocol&quot; transfusion.</description>
        <time_frame>Day of surgery. Approximately 1 day.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells transfusion that were administered in the standard of care</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells transfusion that were washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of &quot;Off-protocol&quot; Transfusions</title>
          <description>The number of standard issued red blood cell units that were transfused to study participants in the washed red blood cell arm of the trial. Additionally, emergency red blood cell transfusions in the standard issued arm of the trial that were administered outside of the study protocol were also included to the definition of &quot;off protocol&quot; transfusion.</description>
          <units>transfusions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Recipient Hemoglobin</title>
        <description>Change in Hemoglobin from pre-transfusion to post-transfusion</description>
        <time_frame>Pre to 6 hours post transfusion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.&#xD;
Standard of care red blood cell transfusion.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.&#xD;
Point-of-care washed red blood cell transfusion.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Recipient Hemoglobin</title>
          <description>Change in Hemoglobin from pre-transfusion to post-transfusion</description>
          <units>units on a scale (g/dl)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" lower_limit="1.6" upper_limit="3.6"/>
                    <measurement group_id="O2" value="2.3" lower_limit="1.4" upper_limit="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Recipient Cell Free Hemoglobin(CFH)</title>
        <description>Change in CFH from pre-transfusion to worst (highest/maximum) post-transfusion</description>
        <time_frame>Pre transfusion until study day 5 or hospital discharge, approximately 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Recipient Cell Free Hemoglobin(CFH)</title>
          <description>Change in CFH from pre-transfusion to worst (highest/maximum) post-transfusion</description>
          <units>units on a scale (mg/dl)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.8" lower_limit="8.9" upper_limit="52"/>
                    <measurement group_id="O2" value="23" lower_limit="6.6" upper_limit="58.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Haptoglobin</title>
        <description>Change in Haptoglobin from pre-transfusion to worst (minimum) post-transfusion</description>
        <time_frame>Pre transfusion to study day 5 or hospital discharge, approximately 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Haptoglobin</title>
          <description>Change in Haptoglobin from pre-transfusion to worst (minimum) post-transfusion</description>
          <units>units on a scale (mg/dl)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-48.5" lower_limit="-95" upper_limit="-16.5"/>
                    <measurement group_id="O2" value="-54" lower_limit="-103" upper_limit="-7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Mechanical Ventilation</title>
        <description>Number of hours subject received mechanical ventilation.</description>
        <time_frame>Up to hospital day 28, or discharge, whichever comes first</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Mechanical Ventilation</title>
          <description>Number of hours subject received mechanical ventilation.</description>
          <units>units on a scale (hours)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.3" lower_limit="5.6" upper_limit="23.5"/>
                    <measurement group_id="O2" value="10.8" lower_limit="5.6" upper_limit="20.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Oxygen Supplementation</title>
        <description>Number of hours subjects received supplemental oxygen.</description>
        <time_frame>Up to day 28, or hospital discharge, whichever comes first</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Oxygen Supplementation</title>
          <description>Number of hours subjects received supplemental oxygen.</description>
          <units>units on a scale (hours)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.7" lower_limit="45.5" upper_limit="142.7"/>
                    <measurement group_id="O2" value="89.5" lower_limit="39.9" upper_limit="180.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sequential Organ Failure Assessment (SOFA) Score</title>
        <description>Worst SOFA score between Day 1 and Day 5. SOFA scores range from 0-24 with 0 meaning no organ dysfunction and 24 means severe dysfunction of all organ systems evaluated. Each of 6 organ systems are scored on a 0-4 scale with the cumulative score being the total SOFA score.</description>
        <time_frame>Through postoperative day 5.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Sequential Organ Failure Assessment (SOFA) Score</title>
          <description>Worst SOFA score between Day 1 and Day 5. SOFA scores range from 0-24 with 0 meaning no organ dysfunction and 24 means severe dysfunction of all organ systems evaluated. Each of 6 organ systems are scored on a 0-4 scale with the cumulative score being the total SOFA score.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="10" upper_limit="14"/>
                    <measurement group_id="O2" value="13" lower_limit="11" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay</title>
        <description>Number of days subject remained in the hospital following their surgical procedure. If the number of days the subject remained in the hospital exceeded 28, a value of 28 is assigned.</description>
        <time_frame>Up to day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <description>Number of days subject remained in the hospital following their surgical procedure. If the number of days the subject remained in the hospital exceeded 28, a value of 28 is assigned.</description>
          <units>units on a scale (days)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="9" upper_limit="17"/>
                    <measurement group_id="O2" value="12" lower_limit="9" upper_limit="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Transfusion Respiratory Complications.</title>
        <description>Development of transfusion-related lung injury (TRALI) or transfusion-associated circulatory overload (TACO).</description>
        <time_frame>Up to day 28</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care Red Blood Cell Transfusion</title>
            <description>Red blood cells that are administered as standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
            <description>Red blood cells that are washed at the point-of-care.</description>
          </group>
        </group_list>
        <measure>
          <title>Post Transfusion Respiratory Complications.</title>
          <description>Development of transfusion-related lung injury (TRALI) or transfusion-associated circulatory overload (TACO).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TACO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TRALI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomization to hospital discharge, death, or day 28 (whichever occurs first).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care Red Blood Cell Transfusion</title>
          <description>Red blood cells transfusion that were administered in the standard of care</description>
        </group>
        <group group_id="E2">
          <title>Point-of-Care Washed Red Blood Cell Transfusion</title>
          <description>Red blood cells transfusion that were washed at the point-of-care.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE (4.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="86"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Profound Anemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>hypoxemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="86"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="86"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Daryl Kor</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>507-255-6051</phone>
      <email>kor.daryl@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

